stroke/albumina

Il collegamento viene salvato negli appunti

Scegli il tipo di ordinamento

Pagina 1 a partire dal 1422 risultati

Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND Since information about the association between serum albumin and risk of stroke is limited the purpose of the present paper was to re-investigate this relationship. METHODS The study followed a cross-sectional design. METHODS In the cross-sectional Norwegian Oslo Health Study the

Albumin therapy in acute stroke patients.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Preclinical studies have recently shown that albumin has neuroprotective effects for stroke in animal models. Thus, we sought to evaluate the effects of albumin therapy in patients with acute cerebral infarcts. We prospectively studied 49 patients with moderate-to-severe cerebral infarcts within the

Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Human serum albumin therapy confers neurobehavioral and histopathologic neuroprotection in adult stroke models. We investigated whether albumin might also be neuroprotective in ischemic brain injury using a transient filament middle cerebral artery occlusion (tfMCAO) model in 10-d-old rat pups

Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Relatively high serum albumin levels compared to low levels have been associated with reduced cardiovascular mortality and coronary heart disease and stroke incidence. The nature of these associations remains undefined. Therefore, widely accepted criteria of Bradford Hill were used to assess the

Could pro-BNP, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes?

Solo gli utenti registrati possono tradurre articoli

Entra registrati

To establish the pathogenesis of ischemic strokes is very important in determining an adequate therapy. The objective was to observe if certain plasma parameters could be used as biomarkers in distinguishing between stroke subtypes. Plasma pro-BNP (chemiluminescence), serum uric acid, bilirubin

Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: A preliminary study.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND Ischemia-modified albumin (IMA) is a sensitive marker of ischemic event. However, limited studies are available regarding role of IMA in acute ischemic stroke (AIS). OBJECTIVE The aim of this study was to evaluate time course of IMA in AIS patient to validate its prognostic

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

OBJECTIVE To investigate early diagnostic effects of serum myelin basic protein (MBP) and ischemic modified albumin (IMA) levels in patients with ischemic stroke. METHODS Fifty patients who presented to an emergency service with acute ischemic stroke between June 2013 to March 2014 were evaluated

Delayed treatment with polynitroxyl albumin reduces infarct size after stroke in rats.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Nitroxides are antioxidants that are known to protect cells from oxidative damage. Polynitroxyl albumin (PNA) is a compound of human serum albumin covalently labeled with nitroxides that exhibits a prolonged half-life and an enhanced antioxidant activity. Adult male Sprague-Dawley rats were

fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Accumulating experimental and clinical data suggest that albumin may be neuroprotective for stroke. Here, we use functional magnetic resonance imaging (fMRI) to evaluate the therapeutic efficacy of albumin and its effects on the recovery of stimuli-induced cerebral hemodynamics. For this purpose,

Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

Stroke is the second largest disease of mortality. The biggest hurdle in designing effective brain drug delivery systems is offered by the blood-brain barrier (BBB), which is highly impermeable to many drugs. Albumin nanoparticles (NP) have gained attention due to their multiple ligand binding sites

Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

1. The aim of the present study was to reveal the effect of transient forebrain ischemia on the regional and temporal changes in the permeability of the blood-brain barrier (BBB) permeability for sodium fluorescein (MW: 376 Da) and Evan's blue-labeled albumin (MW: 67 kDa) in stroke-prone

Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management?

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND The detection of biomarkers such as ischemia-modified albumin (IMA) and heart fatty acid-binding protein (HFABP) is used in the early diagnosis of acute myocardial infarction. As these biomarkers are not organ specific, we tested them in the neurovascular field. METHODS A total of 41

Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND Albumin treatment of ischemic stroke was associated with cardiopulmonary adverse events in previous studies and a low incidence of intracranial hemorrhage. We sought to describe the neurological and cardiopulmonary adverse events in the ALIAS Part 2 Multicenter Trial. METHODS Ischemic

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population　- Comparisons With C-Reactive Protein and Urinary Albumin.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND The ability of cardiovascular biomarkers to predict the incidence of stroke subtypes remains ill-defined in the general population.Methods and Results:The blood levels of B-type natriuretic peptide (BNP) and high-sensitivity C-reactive protein (hs-CRP) and urinary albumin corrected by

Prognostic significance of serum albumin level changes in acute ischemic stroke: the role of biological and analytical variation.

Solo gli utenti registrati possono tradurre articoli

Entra registrati

BACKGROUND Animal studies have shown a neuroprotective effect of human serum albumin (sAlb) in ischemic stroke (IS). Previous studies have shown an association of high sAlb with better outcome. Our aim is to investigate the kinetics of sAlb in acute IS and its possible correlation with outcome

Precedente
1
2
3
4
5
6
...
94
95
Il prossimo

Unisciti alla nostra
pagina facebook

Herbal & Natural Medicine

Il database di erbe medicinali più completo supportato dalla scienza

Funziona in 55 lingue
Cure a base di erbe sostenute dalla scienza
Riconoscimento delle erbe per immagine
Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
Leggi le pubblicazioni scientifiche relative alla tua ricerca
Cerca le erbe medicinali in base ai loro effetti
Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti

Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate

stroke/albumina

Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study.

Albumin therapy in acute stroke patients.

Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke.

Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

Could pro-BNP, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes?

Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: A preliminary study.

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases.

Delayed treatment with polynitroxyl albumin reduces infarct size after stroke in rats.

fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains.

Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.

Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats.

Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management?

Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population - Comparisons With C-Reactive Protein and Urinary Albumin.

Prognostic significance of serum albumin level changes in acute ischemic stroke: the role of biological and analytical variation.

Il database di erbe medicinali più completo supportato dalla scienza

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population　- Comparisons With C-Reactive Protein and Urinary Albumin.